About Supreem Pharmaceuticals
Supreem Pharmaceuticals is a company based in Bengaluru (India) founded in 1985. It operates as a B2B and D2C. The company has 207 employees as of March 31, 2023. Supreem Pharmaceuticals offers products and services including Stabilized Vitamins, Herbal Extracts, Tasteless Minerals, and Value Added APIs. Supreem Pharmaceuticals operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Bengaluru, India
- Employees 207 as on 31 Mar, 2023
-
Sectors
AgricultureHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Supreem Pharmaceuticals Mysore Private Limited
- Date of Incorporation 16 Aug, 1996
- Jurisdiction Nanjangudu, Karnataka, India
-
Annual Revenue
$10.04 M (USD)7.32as on Mar 31, 2023
-
Net Profit
-$1.15 M (USD)-617.53as on Mar 31, 2023
-
EBITDA
-$817.7 K (USD)-212.16as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
207
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Supreem Pharmaceuticals
Supreem Pharmaceuticals offers a comprehensive portfolio of products and services, including Stabilized Vitamins, Herbal Extracts, Tasteless Minerals, and Value Added APIs.
Enhanced vitamins for stability in food and pharma applications.
Extracts from pesticide-free materials for safe human use.
Minerals formulated for compatibility in beverages and supplements.
Active ingredients with improved stability for therapeutic uses.
Funding Insights of Supreem Pharmaceuticals
Detailed funding history for Supreem Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Supreem Pharmaceuticals
Investment portfolio details for Supreem Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Supreem Pharmaceuticals
Detailed financials for Supreem Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Supreem Pharmaceuticals Comparisons
Peer comparison for Supreem Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Supreem Pharmaceuticals
Supreem Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Supreem Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Supreem Pharmaceuticals
Complete news archive for Supreem Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supreem Pharmaceuticals
Supreem Pharmaceuticals was founded in 1985.
Supreem Pharmaceuticals is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
As of Mar 31, 2023, the latest employee count at Supreem Pharmaceuticals is 207.
Annual revenue of Supreem Pharmaceuticals is $10.04M as on Mar 31, 2023.
Supreem Pharmaceuticals produces stabilized vitamins, minerals, and herbal extracts to enhance product stability and shelf life. They use expert RD to address sensitivity issues in food and pharmaceutical applications. Based in Mysuru, India, they serve over 400 customers across 30 export countries with certified, high-quality solutions for dietary supplements and cosmetic ingredients.
Supreem Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Supreem Pharmaceuticals offers Stabilized Vitamins, Herbal Extracts, Tasteless Minerals, and Value Added APIs.